).
To establish the physiological relevance of Nod2-mediated, ssRNAinduced activation of IRF3, we next evaluated the function of endogenous Nod2 in inducing IRF3-interferon after ssRNA treatment. For these studies we used human lung epithelial A549 cells, as these cells are permissive to most viruses that have ssRNA genomes and endogenously express various PRRs. Treatment of these cells with ssRNA resulted in higher expression of Nod2 (Fig. 1b) ; Nod1 expression remained unchanged (data not shown). Nod2-specific small interfering RNA (siRNA) diminished Nod2 expression in ssRNA-treated A549 cells ( Supplementary  Fig. 2a ) and impaired ssRNA-induced activation of IRF3 and IFN-β ( Fig. 1c and Supplementary Fig. 2b) .
Similarly, ssRNA-induced production of IFN-β was lower in bone marrow-derived macrophages (BMMs) and mouse embryo fibroblasts (MEFs) isolated from Nod2-deficient than in those from wild-type mice (Fig. 1d,e) . In contrast, wild-type and Nod2-deficient BMMs and MEFs produced similar amounts of IFN-β after treatment with poly(I:C) (double-stranded RNA that activates TLR3; Supplementary Fig. 2c ). The ability of poly(I:C) to induce interferon (via TLR3) in both wild-type and Nod2-deficient MEFs showed that the IRF3-interferon pathway is intact in Nod2-deficient mice. Furthermore, administration of poly(I:C) in vivo resulted in the production of similar concentrations of IFN-β in wildtype and Nod2-deficient mice (Supplementary Fig. 2d ). Thus, our results obtained with cell lines and primary cells demonstrate that activation of Nod2 by ssRNA results in IFN-β production.
Nod2 facilitates virus-induced interferon production
To further confirm the ability of Nod2 to launch an antiviral response, we infected 293 cells with RSV. RSV induced activation of IRF3 and IFN-β in 293 cells expressing HA-Nod2 but not in 293 cells expressing HA-Nod1 (Fig. 2a,b) . Inactivation of virion particles with ultraviolet light abolished the ability of RSV to activate IRF3 in Nod2-expressing cells (Fig. 2a) . The inability of RSV inactivated by ultraviolet light to activate IRF3 indicated that an intact viral RNA genome is essential for Nod2 activation. The direct function of viral components in Nod2 activation was further confirmed by the loss of IRF3 activation after inhibition of RSV cellular entry with an RSV-neutralizing antibody (specific for the RSV fusion protein; Supplementary Fig. 2e) .
We established the functional importance of Nod2 in antiviral responses with the interferon-sensitive vesicular stomatitis virus (VSV). Plaque assay of VSV titers obtained from 293 cells expressing HA-Nod2 or HA-Nod1 showed that cells expressing HA-Nod2 had much lower viral titers (Fig. 2c) . Like VSV, RSV titers were lower in Nod2-expressing cells than in Nod1-expressing cells (Fig. 2d) . Human parainfluenza virus type 3 (ref. 17) and VSV 18 also activated IRF3 in Nod2-expressing 293 cells (Supplementary Fig. 3a) . In contrast, vaccinia virus, a DNA virus, failed to activate IRF3 in Nod2-expressing cells (Supplementary Fig. 3b ). These results demonstrated that like the RLH receptors RIG-I and Mda5, Nod2 can function as a cytoplasmic PRR for a viral ssRNA genome (viral ssRNA).
We next evaluated the function of endogenous Nod2 in inducing IRF3-interferon in response to RSV infection. Published studies have described IRF3 activation and IFN-β production in RSV-infected A549 cells as early as 2 h after infection 19, 20 . Although uninfected A549 cells did not have detectable expression of Nod2, RSV infection resulted in higher Nod2 expression within 2 h of infection (Fig. 3a) . RSV infection failed to induce Nod1 expression (data not shown). Nod2-specific siRNA markedly diminished Nod2 expression after RSV infection ( Supplementary  Fig. 4a ) and resulted in less activation of IRF3 and IFN-β after RSV infection ( Fig. 3b and Supplementary Fig. 4b ). The effect was more pronounced during early time points after infection (4 h and 6 h) than later (10 h) after infection (Fig. 3b) . This result suggests that Nod2 is critical for the early antiviral response, whereas during late time periods after infection, other PRRs (such as RIG-I) may activate the IRF3-interferon pathway. Indeed, as shown before 20 , we found that RIG-I expression in A549 cells was detectable only at late time points after infection with RSV ( Supplementary Fig. 4c ). In addition, the early antiviral response was independent of RIG-I, because silencing of RIG-I had no effect in IFN-β expression during early RSV infection ( Supplementary  Fig. 4d,e) . Like A549 cells, MEFs did not express abundant Nod2 until early time points after RSV infection, and RIG-I was undetectable until late time points after RSV infection ( Supplementary Fig. 4f,g ). Thus, temporal expression of Nod2 and RIG-I during early and late infection, respectively, may facilitate optimal sustained interferon production by virus-infected cells.
Next we examined the function of Nod2 in primary normal human bronchial epithelial cells (NHBE cells), as these cells constitute the main cell type infected by RSV in humans. RSV rapidly induced Nod2 expression in NHBE cells (Supplementary Fig. 5 ). Nod2 was essential for interferon production, as Nod2-specific siRNA markedly diminished IFN-β production by RSV-infected NHBE cells (Fig. 3c) . We further established the critical function of Nod2 by demonstrating that BMMs, MEFs and alveolar macrophages derived from Nod2-deficient mice produced less IFN-β than did their wild-type counterparts after RSV infection (Fig. 3d-f) . Nod2-deficient MEFs and BMMs also showed defective IFN-β production after infection with influenza A/PR/8/34 (H1N1) virus (Supplementary Fig. 6 ). Collectively these data show an important function for endogenous Nod2 in the induction of antiviral immune responses.
Nod2 interacts with viral ssRNA
We next investigated the function of viral ssRNA in Nod2 activation. Viral ssRNA genome isolated from purified RSV virion particles activated IRF3 only in Nod2-expressing cells (Fig. 4a ). An intact ssRNA genome was required for Nod2 activation, as treatment of the viral ssRNA with RNAse abolished IRF3 activation (Fig. 4a) . Viral ssRNA uses Nod2 for interferon production, as we found less IFN-β production after viral ssRNA treatment in MEFs and BMMs isolated from Nod2-deficient mice than in those from wild-type mice (Fig. 4b,c) .
The function of viral ssRNA as an activator of Nod2 was further demonstrated by the interaction of viral ssRNA with Nod2 in a cellular milieu. We immunoprecipitated HA-Nod2 from RSV-infected 293 cells transfected with HA-Nod2 and amplified bound RNA with primers specific for either glyceraldehyde phosphate dehydrogenase (GAPDH; control) or RSV nucleocapsid protein. These experiments demonstrated association of Nod2 with viral RNA but not with control RNA (Fig. 4d) . In a cell-free assay, we incubated HA-Nod2 bound to HA-agarose beads with RSV ssRNA genome or mRNA isolated A r t i c l e s from cells. After incubation, we amplified bound RNA with primers specific for either GAPDH or RSV nucleocapsid protein; we detected interaction of Nod2 with RSV ssRNA (Fig. 4e) . In contrast, GAPDH mRNA (total cellular mRNA is enriched for this) did not associate with Nod2 (Fig. 4e) . We also noted a failure of Nod1 to interact with viral ssRNA (data not shown). These results demonstrate that interaction of viral ssRNA with Nod2 results in its activation and subsequent induction of interferon production.
MAVS is required for Nod2-mediated responses
We next focused on the mechanism used by Nod2 to activate IRF3-interferon. As both RIG-I and Nod2 have caspase-recruitment domains (CARDs) 6-9 , we speculated that similar to RIG-I, Nod2 may also interact with MAVS. In addition, a study has shown that the NLR family member NLRX1 interacts with mitochondria-localized MAVS through its NBD, a domain also found in Nod2 (ref. 11). The interaction of Nod2 with MAVS was essential for Nod2-mediated activation of antiviral responses, as MAVS-specific siRNA ( Supplementary  Fig. 7 ) and Nod2-specific siRNA (Fig. 5a ) diminished RSV-induced production of IFN-β from infected NHBE cells to a similar extent.
We obtained similar results with MEFs derived from MAVS-deficient mice infected with RSV or transfected with viral or synthetic ssRNA (Fig. 5b,c) . Influenza A virus also required MAVS for interferon production, as IFN-β production by Nod2-deficient and MAVS-deficient MEFs was diminished to a similar extent after influenza A infection (Supplementary Fig. 8 ). These results demonstrate that MAVS is critical for virus-induced Nod2-mediated interferon production. We next examined interaction of Nod2 with MAVS. Initially we investigated the ability of activated Nod2 to translocate to the mitochondria. Immunoblot analysis of mitochondrial extracts from RSV-infected Nod2-expressing cells showed that although approximately 6-7% of Nod2 was located in mitochondria in uninfected cells, RSV infection resulted in enrichment of Nod2 in mitochondria (40-45% of total cellular Nod2; Supplementary Fig. 9a,b) . Immunofluorescence analysis also showed localization of endogenous Nod2 together with mitochondria in RSV-infected A549 cells (Supplementary Fig. 9c) . To study the interaction of Nod2 with MAVS, we transfected 293 cells with HA-Nod2 and green fluorescent protein (GFP)-tagged MAVS. Coimmunoprecipitation analysis showed interaction of Nod2 with MAVS (Fig. 6a) , and this interaction was enhanced after RSV infection. Cells had high expression of GFP-MAVS, as detected by immunoblot analysis of cell lysates with antibody to GFP (anti-GFP; Fig. 6a) , and a substantial amount of HA-Nod2 was bound to the anti-HA-agarose beads used to precipitate the HA-Nod2-GFP-MAVS complex (Fig. 6b) . In contrast to Nod2, Nod1 failed to interact with MAVS (Supplementary Fig. 9d ). Double-labeling immunofluorescence studies with RSV-infected 293 cells expressing GFP-MAVS and HA-Nod2 confirmed the colocalization of Nod2 and MAVS (Fig. 6c) . Similarly, RSV infection of A549 cells (Fig. 6d) and NHBE cells (Fig. 6e) enhanced the colocalization of endogenous Nod2 with endogenous MAVS. These results demonstrate that Nod2 interacts with MAVS during virus infection.
Nod2 can activate the NF-κB and mitogen-activated protein kinase pathways through the kinase RICK (also known as Rip2, CARDIAK, CCK or Ripk2) 21, 22 . Bacterial products such as MDP specifically stimulate Nod2 and result in NF-κB activation via RICK. However, treatment of Nod2-expressing 293 cells with MDP did not activate IRF3 (Supplementary Fig. 10a) . Likewise, treatment of NHBE cells and BMMs with MDP did not result in IFN-β production ( Supplementary  Fig. 10b,c) . In addition, RICK may not be important in interferon induction by Nod2, as silencing of endogenous RICK expression did not alter Nod2-mediated production of IFN-β in RSV-infected cells (Supplementary Fig. 11 ). We also examined the efficiency of the interaction between Nod2 and MAVS relative to that of RIG-I and MAVS. Although both Nod2 and RIG-I associated with MAVS, the RIG-I-MAVS interaction was slightly more efficient than the Nod2-MAVS interaction (Supplementary Fig. 12a ). In addition, we also noted that in RSV-infected cells, Nod2 interacted more efficiently with MAVS than with RICK ( Supplementary Fig. 12b ). However, Nod2 efficiently interacted with RICK in cells stimulated with the well-established Nod2 stimulator MDP (Supplementary Fig. 12b ). Thus, we speculate that Nod2 uses either RICK or MAVS, depending on the stimulus (for example, MDP versus ssRNA) to activate either IRF3 or NF-κB.
In addition to IRF3, NF-κB activation is required for the expression of interferon genes. Although IRF3 alone is able to induce the transcription of interferon genes, the transactivating function of NF-κB acts synergistically with IRF3 to promote optimal interferon expression 23 . This is also true for Nod2-mediated interferon expression, as suppressing NF-κB activity in RSV-infected cells diminished interferon expression via activated Nod2 by 30-35%; as expected, expression of the NF-κB-dependent TNF gene in RSV-infected cells was diminished by 80% (Supplementary Fig. 13 ). On the basis of these results, we speculate that Nod2 activated by stimulation with viral ssRNA interacts with MAVS to induce activation of both IRF3 and NF-κB in a way similar to that of RLHs 6 . In contrast, Nod2 activated by bacterial products (such as MDP) activates NF-κB via RICK. Further detailed studies are needed to investigate the function of Nod2 in activating the NF-κB pathway during virus infection and the function of MAVS and RICK during these events.
MAVS interacts with the LRR-NBD domains of Nod2
The CARD of RIG-I promotes its association with MAVS, whereas NLRX1 uses its NBD to interact with MAVS. Thus, we next investigated the function of the NBD, CARD and LRR domains of Nod2 in MAVS association. For these studies, we generated various Nod2 deletion mutants tagged with both histidine (His) and Myc:∆CARD (a Nod2 mutant lacking both CARDs), ∆NBD (a Nod2 mutant lacking the NBD) and ∆LRR (a Nod2 mutant lacking the LRR domain; Fig. 7a) . We expressed these mutants in 293 cells along with GFP-MAVS. We obtained lysates of these cells and precipitated the lysates with nickel-agarose beads and, after washing the beads, analyzed the proteins bound to the beads by immunoblot with anti-GFP. Although ∆CARD was able to interact with MAVS, neither ∆NBD nor ∆LRR associated with MAVS (Fig. 7b) . The various Nod2 mutant-expressing cells expressed similar amounts of GFP-MAVS (Fig. 7c) . In addition, similar amounts of His-Myc-tagged Nod2 mutants were bound to the nickel-agarose beads in the experimental conditions used to study the interaction of MAVS with the Nod2 mutants (Fig. 7d) . These results indicate that unlike RIG-I, the CARDs 
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It is well known that RSV causes lung disease by inducing pneumonia, a massive inflammation of the lungs 31 . A larger viral burden ultimately results in enhanced inflammation and exaggerated lung disease due to flooding of alveolar spaces with edema fluid. This occurs as a result of enhanced permeability of the epithelial barrier due to apoptosis of airway epithelial cells. RSV infection resulted in more severe lung pathology in Nod2-deficient mice, as shown by staining of lung sections with hematoxylin and eosin at 3 and 5 d after infection (Fig. 8c) . We noted massive peribronchial lymphocytic inflammation and filling of the lumen with exudates of infiltrating neutrophils and mucus. Neutrophils constitute the main immune cells infiltrating the lung of RSV-infected mice and humans and a large number of these cells in the airway causes severe immunopathology associated with RSV clinical disease [32] [33] [34] . To examine neutrophil accumulation in the lungs, we did a myeloperoxidase (MPO) activity assay 35, 36 with lung homogenates of RSV-infected wild-type and Nod2-deficient mice. Greater RSV-induced enhancement of neutrophil activity was visible in the lung tissue of Nod2-deficient mice (~35%) than in that of wild-type mice (~4% ;  Fig. 8d) . The enhanced inflammation in the respiratory tract of Nod2-deficient mice was also confirmed by higher concentrations of proinflammatory cytokines and chemokines (such as tumor necrosis factor, IL-10 and RANTES) in the BAL fluid of infected Nod2-deficient than in that of wild-type mice (Supplementary Fig. 15b-d) . A high RSV load has been associated with enhanced apoptosis of airway epithelial cells and infiltrating neutrophil granulocytes, which contributes to the development of lung lesions and injury 37 . Indeed, in situ apoptosis analysis of lung sections by TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling) showed enhanced apoptosis in the lungs of RSV-infected Nod2-deficient mice relative to that in the lungs of RSV-infected wild-type mice (Fig. 8e) .
Notably, RSV-infected Nod2-deficient mice lost considerably more body weight and had diminished survival relative to their wild-type counterparts ( Fig. 8f and Supplementary Fig. 16 ). We also found less IFN-β production in the BAL fluid of influenza A virus-infected Nod2-deficient mice than in that of influenza A virus-infected wildtype mice (Supplementary Fig. 17 ). These results demonstrated that Nod2 is a critical component of host antiviral defense mechanisms.
of Nod2 are not important for its interaction with MAVS. However, the NBD and LRR domains of Nod2 are required for the MAVS association. We further confirmed that conclusion by examining the functionality of the Nod2 mutants in activating IRF3. Infection of 293 cells transfected with either wild-type or mutant (∆CARD, ∆NBD or ∆LRR) Nod2 constructs showed that wild-type Nod2 and ∆CARD induced IRF3 activation after infection with RSV, but neither ∆NBD nor ∆LRR did so (Supplementary Fig. 14) .
Function of Nod2 in the host antiviral defense
Finally, we assessed the physiological function of Nod2 by infecting wild-type and Nod2-deficient mice with RSV. The mouse model of RSV infection mimics virus infection in humans, as infected mice can develop disease states resembling pneumonia 24, 25 ; in addition, RSVinfected mice induce a robust antiviral response in the respiratory tract characterized by production of IFN-β and expression of interferondependent genes such as Mx1 during early RSV infection (within 12 h of infection) [24] [25] [26] [27] [28] [29] [30] . Moreover, RSV is sensitive to interferon in infected mice, as a dose of interferon as low as 200 units per ml inhibits RSV infection in mice by 100-fold (ref. 26) . During RSV infection of the mouse respiratory tract, interferon is induced early during infection (at 12 h to 2 d after infection), but its production is lost at 3 d after infection [24] [25] [26] [27] [28] [29] [30] . This observation suggests that interferon is important in restricting the spread of RSV during early infection and that the production of interferon dictates the clinical outcome of the disease (for example, lung inflammation and apoptosis of airway cells).
We infected wild-type and Nod2-deficient mice with a sublethal dose of RSV (5 × 10 6 plaque-forming units per mouse, delivered by intranasal inoculation), then collected lungs and bronchoalveolar lavage (BAL) fluid at various times. We found expression of mouse Nod2 in RSV-infected lungs at 1 d after infection, and this expression was lost at 4 d after infection (Supplementary Fig. 15a ). This result suggests an important function for Nod2 in interferon expression, as the interferon-induction kinetics correlated with the Nod2-expression kinetics [24] [25] [26] [27] [28] [29] [30] . Nod2-deficient mice had lower IFN-β production in the respiratory tract and higher viral titers than did wild-type mice (Fig. 8a,b) . Other PRRs, including RIG-I, may also be involved in activating an antiviral response against paramyxoviruses like RSV 20 . For some time, the in vivo relevance of RIG-I in antiviral function was not documented because of the embryonic death of most RIG-I-deficient mice 38 . However, one strain of RIG-I-deficient mice generated by crossing RIG-I-heterozygous mice with ICR outbred mice, followed by intercrossing of the resultant RIG-I-heterozygous mice 38 , survives to adulthood. These RIG-I-deficient mice show impaired interferon production and enhanced susceptibility to two positive-sense ssRNA viruses: encephalomyocarditis virus and Japanese encephalitis virus 38 . However, no studies have been done to demonstrate the importance of RIG-I in activating the antiviral host defense apparatus against negative-sense ssRNA viruses (such as paramyxoviruses).
Uninfected mice have low Nod2 expression 39 , and we have shown that its expression increased after viral infection. Our observation is similar to those of published studies demonstrating that most PRRs (such as RIG-I) have low expression but their expression is higher after pathogen invasion 40, 41 . Similarly, we found that viruses mediated the induction of Nod2 in various cells. Although in our studies we noted induction of Nod2 in virus-infected MEFs, one study has reported that MDP is unable to induce Nod2 expression in wild-type MEFs; this observation may have been due to a defect in MDP transport to the cytoplasm 42 . Several other studies have shown that Nod2 expression is stimulated by various bacteria and bacterial components 40, 41 . Similarly, expression of RIG-I (ref. 43) and in uninfected, unstimulated wild-type MEFs is negligible, but treatment of cells with PAMPs results in upregulation of RIG-I expression 43 . This mechanism of restricting expression of PRRs in unstimulated cells may be critical for preventing uncontrolled inflammation.
Although Nod2 can be activated by MDP [7] [8] [9] [10] , so far no studies have demonstrated direct binding of MDP to Nod2; it is known only that lack of Nod2 expression results in loss of MDP responsiveness. Thus, MDP could directly interact with Nod2 or associate with a protein or proteins that form a complex with Nod2. In that context, the interaction of viral ssRNA with Nod2 demonstrated here could also be mediated indirectly via 'bridging' proteins. Interaction of the ssRNA genomes of viruses with RIG-I has also been noted before 44, 45 . In addition to Nod2, cryopyrin (Nalp3), another NLR protein, activates the inflammasome and leads to IL-1 production after stimulation with bacterial and viral (influenza A) RNA [46] [47] [48] . Although NLRs such as cryopyrin [46] [47] [48] serve an important function in innate immunity by activating the inflammasome and inhibiting interferon production, respectively, no studies have determined whether other NLRs, such as Nod2, can directly contribute to antiviral responses by inducing interferon production.
Published studies have shown that transfection of Nod2 alone (in the absence of any stimulant) into wild-type MEFs results in substantial NF-κB activation 49 . However, we found that overexpression of Nod2 in 293 cells did not induce marked activation of IRF3 in the absence of external stimuli (such as RSV or synthetic or viral ssRNA). Thus, it seems that Nod2-mediated activation of IRF3 is stimulus dependent, whereas RICK activation is stimulus independent. In summary, our findings have demonstrated that in addition to RIG-I, Mda5 and TLRs, Nod2 can also function as a viral PRR and participate in inducing antiviral signaling. Distinct temporal activation of various PRRs may be needed to generate optimal antiviral responses, and various viruses may trigger the induction of different classes of PRRs.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
